Neurocardiogenetics: Exploring the association of rare <i>RYR2</i> variants with neuropsychiatric disorders in general and disease populations

Overlapping neuropsychiatric and cardiac features in rare monogenic syndromes stem from shared gene expression. Pathogenic gain-of-function <i>RYR2</i> variants, leading to a lethal cardiac arrhythmia syndrome known as catecholaminergic polymorphic ventricular tachycardia (CPVT), have also been associated with neuropsychiatric disorders such as epilepsy, schizophrenia, and intellectual disability. Neuropsychiatric phenotypes have not been reported in patients with calcium release deficiency syndrome (CRDS), a recently described inherited arrhythmia disorder distinct from CPVT caused by loss-of-function <i>RYR2</i> variants. Whether there is a robust association between ultra-rare <i>RYR2</i> variants and neuropsychiatric phenotypes in large population databases and disease cohorts has not been determined to-date. Here, we explore the association of <i>RYR2</i> variants with neuropsychiatric disorders in 748,879 individuals from multiple biobanks, including 155,236 non-Europeans, and in neuropsychiatric disease cohorts. Our analyses suggest an association between <i>RYR2</i> variants and epilepsy, while links with other disorders were not robust. In this process, a previously uncharacterized <i>RYR2</i> variant (p.Y4962N) with conflicting reported pathogenicity was found to be associated with both cardiac and neuropsychiatric phenotypes. To better understand the potential impact of the variant, we further assessed its mechanistic impact and found that RyR2<i>-</i>p.Y4962N results in loss-of-function. Such a finding has not been reported previously in association with <i>RYR2</i> loss-of-function variants or CRDS. Altogether, our study expands our understanding of the involvement of <i>RYR2</i> variants in neurocardiac phenotypes in general populations and disease cohorts, which could enhance personalized medicine efforts by integrating cardiac and neuropsychiatric risk profiles.

Authors

Institutions

Publication Details

Journal
Journal of Neurogenetics
Published
2026-02-26
DOI
https://doi.org/10.1080/01677063.2026.2632080
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neurocardiogenetics: Exploring the association of rare RYR2 variants with neuropsychiatric disorders in general and disease populations

John Paul Estillore, Glen F. Tibbits, Shubhayan Sanatani, Dania Kallas et al.
Journal of Neurogenetics
Genomics and Rare Diseases
article

Neurocardiogenetics: Exploring the association of rare RYR2 variants with neuropsychiatric disorders in general and disease populations

John Paul Estillore, Glen F. Tibbits, Shubhayan Sanatani, Dania Kallas, Saif Dababneh, Thomas M. Roston, Ruiwu Wang, Sixuan Tan, S R Wayne Chen, Jinhong Wei
article en

Abstract

Overlapping neuropsychiatric and cardiac features in rare monogenic syndromes stem from shared gene expression. Pathogenic gain-of-function <i>RYR2</i> variants, leading to a lethal cardiac arrhythmia syndrome known as catecholaminergic polymorphic ventricular tachycardia (CPVT), have also been associated with neuropsychiatric disorders such as epilepsy, schizophrenia, and intellectual disability. Neuropsychiatric phenotypes have not been reported in patients with calcium release deficiency syndrome (CRDS), a recently described inherited arrhythmia disorder distinct from CPVT caused by loss-of-function <i>RYR2</i> variants. Whether there is a robust association between ultra-rare <i>RYR2</i> variants and neuropsychiatric phenotypes in large population databases and disease cohorts has not been determined to-date. Here, we explore the association of <i>RYR2</i> variants with neuropsychiatric disorders in 748,879 individuals from multiple biobanks, including 155,236 non-Europeans, and in neuropsychiatric disease cohorts. Our analyses suggest an association between <i>RYR2</i> variants and epilepsy, while links with other disorders were not robust. In this process, a previously uncharacterized <i>RYR2</i> variant (p.Y4962N) with conflicting reported pathogenicity was found to be associated with both cardiac and neuropsychiatric phenotypes. To better understand the potential impact of the variant, we further assessed its mechanistic impact and found that RyR2<i>-</i>p.Y4962N results in loss-of-function. Such a finding has not been reported previously in association with <i>RYR2</i> loss-of-function variants or CRDS. Altogether, our study expands our understanding of the involvement of <i>RYR2</i> variants in neurocardiac phenotypes in general populations and disease cohorts, which could enhance personalized medicine efforts by integrating cardiac and neuropsychiatric risk profiles.

Journal of Neurogenetics
University of British Columbia (CA), Simon Fraser University (CA), Population Health Research Institute (CA), Regenerative Medicine Institute (MX), St. Paul's Hospital (CA), BC Children's Hospital (CA), Libin Cardiovascular Institute of Alberta (CA), Hamilton Health Sciences (CA)
Good health and well-being
Openalex Percentile: Top 40%
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.